TIRmed Pharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.68M

  • Investors
  • 8

TIRmed Pharma General Information

Description

Developer of a non-steroid treatment of eczema designed to dampen inflammation and relieve itching caused due to innate immune responses. The company offers chemically stabilized single-stranded oligonucleotide formulated in a cream form, enabling atopic dermatitis patients with self-applied and easy-to-use at-home anti-itch treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Alviksvägen 1
  • 167 53 Stockholm
  • Sweden
+46 070-049
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Alviksvägen 1
  • 167 53 Stockholm
  • Sweden
+46 070-049

TIRmed Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TIRmed Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 09-Apr-2025 $4.68M Completed Generating Revenue
5. Later Stage VC 01-Jan-2023 Completed Generating Revenue
4. Early Stage VC 01-Jan-2021 Completed Generating Revenue
3. Early Stage VC 20-Nov-2020 Completed Generating Revenue
2. Grant 01-Dec-2019 $55.3K $170K Completed Startup
1. Early Stage VC $170K $170K Completed Startup
To view TIRmed Pharma’s complete valuation and funding history, request access »

TIRmed Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view TIRmed Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

TIRmed Pharma Patents

TIRmed Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022229350-A2 Single-stranded oligonucleotides for use in the medical treatment and/or prophylaxis of virus infections Inactive 30-Apr-2021
WO-2022229350-A3 Single-stranded oligonucleotides for use in the medical treatment and/or prophylaxis of virus infections Inactive 30-Apr-2021
EP-3679136-A1 Single stranded oligonucleotides inhibiting endocytosis Pending 06-Sep-2017
ES-2834906-T3 Single chain oligonucleotides for use in the medical treatment of skin disorders Active 15-Jun-2015
CA-2989371-A1 Single-stranded oligonucleotides for use in the medical treatment of skin disorders Active 15-Jun-2015 C12N15/117
To view TIRmed Pharma’s complete patent history, request access »

TIRmed Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TIRmed Pharma Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sciety Venture Capital Minority
Nolsterby Invest Family Office Minority
Almi Invest Venture Capital Minority
STOAF (Stockholms Affärsänglar) Venture Capital Minority
European Union Government
You’re viewing 5 of 8 investors. Get the full list »

TIRmed Pharma FAQs

  • When was TIRmed Pharma founded?

    TIRmed Pharma was founded in 2018.

  • Where is TIRmed Pharma headquartered?

    TIRmed Pharma is headquartered in Stockholm, Sweden.

  • What is the size of TIRmed Pharma?

    TIRmed Pharma has 6 total employees.

  • What industry is TIRmed Pharma in?

    TIRmed Pharma’s primary industry is Drug Discovery.

  • Is TIRmed Pharma a private or public company?

    TIRmed Pharma is a Private company.

  • What is TIRmed Pharma’s current revenue?

    The current revenue for TIRmed Pharma is .

  • How much funding has TIRmed Pharma raised over time?

    TIRmed Pharma has raised $6.69M.

  • Who are TIRmed Pharma’s investors?

    Sciety, Nolsterby Invest, Almi Invest, STOAF (Stockholms Affärsänglar), and European Union are 5 of 8 investors who have invested in TIRmed Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process